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Abstract
Background: Postpartum family planning (PPFP) information and services can prevent maternal and child
morbidity and mortality in low-resource countries, where high unmet need for PPFP remains despite opportunities
offered by routine postnatal care visits. This study aims to identify a package of PPFP interventions and determine
its effectiveness on the uptake of contraceptive methods during the first year postpartum. We hypothesize that
implementing a PPFP intervention package that is designed to strengthen existing antenatal and postnatal care
services will result in an increase in contraceptive use.
Methods: This is an operational research project using a complex intervention design with three interacting
phases. The pre-formative phase aims to map study sites to establish a sampling frame. The formative phase
employs a participatory approach using qualitative methodology to identify barriers and catalysts to PPFP uptake to
inform the design of a PPFP intervention package. The intervention phase applies a cluster randomized-controlled
trial design based at the primary healthcare level, with the experimental group implementing the PPFP package,
and the control group implementing usual care. The primary outcome is modern contraceptive method uptake at
twelve months postpartum. Qualitative research is embedded in the intervention phase to understand the
operational reasons for success or failure of PPFP services.
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Discussion: Designing, testing, and scaling-up effective, affordable, and sustainable health interventions in low-
resource countries is critical to address the high unmet need for PPFP. Due to socio-cultural complexities
surrounding contraceptive use, this research assumes that this is more effectively accomplished by engaging key
stakeholders, including adolescents, women, men, key community members, service providers, and policy-makers.
At the individual level, knowledge, attitudes, and behaviors of women and couples toward PPFP will likely be
influenced by a set of low-cost interventions. At the health service delivery level, the implementation of this trial
will probably require a shift in behavior and accountability of providers regarding the systematic integration of
PPFP into their clinical practice, as well as the optimization of health service organization to ensure the availability
of competent staff and contraceptive supplies.
Trial registration: Retrospectively registered in the Pan African Clinical Trials Registry (PACTR201609001784334, 27
September 2016).
Keywords: Health services operational research, Postpartum family planning, Pregnancy, Antenatal care, Postnatal
care, Public health intervention package, Contraceptive uptake, Complex intervention, Qualitative research, Cluster
randomized controlled trial
Background
Ignoring the contraceptive needs of postpartum
women are missed opportunities in health service de-
livery to ensure that every woman and her family can
enjoy the health, social, and economic benefits of
family planning (FP).
By spacing the birth-to-pregnancy interval by at least
two years and the inter-birth interval by at least three
years, the use of effective postpartum contraceptive
methods in less developed countries could prevent poor
maternal, perinatal, and neonatal health outcomes, in-
cluding stillbirth, prematurity, low birth weight, neonatal
and maternal mortality [1–3]. However, among women
in developed countries, the impact of short
birth-to-pregnancy intervals is mixed considering recent
studies [4–6]. PPFP can be therefore defined as the pre-
vention of unwanted pregnancies and closely spaced
pregnancies during the first 12 months after delivery –
during this period, pregnancy poses the greatest risks to
both the mother and baby [7].
Despite the importance given by the International
Conference on Population and Development to FP and
timely birth spacing (“that all couples and individuals
have the basic right to determine freely and responsibly
the number and spacing of their children and to have the
information, education and means to do so”), unmet
need for FP in the postpartum period remains unaccept-
ably high and far exceeds the FP unmet need of other
women. Birth-to-pregnancy intervals in 50% or more of
pregnancies in low- and middle-income countries are
too short – at less than 23 months [8]. Depending on
the definitions of unmet need for PPFP and according to
estimates derived from Demographic Health Survey
(DHS) data analysis from 57 countries during 2005–
2013, the proportion of postpartum women who no lon-
ger wanted children or wanted to postpone another child
for at least two years but were not using a contraceptive
method ranged from 32% (at the end of amenorrhea) to
62% (soon after birth and before the sixth week postpar-
tum; this prospective definition assumes that women
should be offered a contraceptive method even while they
are still amenorrheic and does not take into account the
protection offered by amenorrhea and abstinence) [9].
The unmet need soon after birth even reaches 75% for the
West and Central Africa region. The overall goal of our
study is to address this high unmet need for PPFP.
Routine reproductive, maternal, newborn and child
health (RMNCH) services offer frequent points of con-
tact for providers and women and are key opportunities
to address the contraceptive needs of postpartum
women and couples [10]. PPFP should therefore be an
integral part of RMNCH services. Despite observed ad-
vances in access to RMNCH services in many
Sub-Saharan African countries in recent decades, pro-
gress is weak regarding effective postpartum contracep-
tive use [8, 11, 12]. There are multiple factors that can
be examined from the perspective of the demand side
on the one hand (factors related to the demand of health
services by women), and supply side on the other (fac-
tors related to the provision of health services).
From the demand side: first, abstinence from sex for
long periods after childbirth. Second, reliance on amen-
orrhea are common traditional PPFP methods, especially
in Sub-Saharan Africa, where women generally breast-
feed their babies up to two years, although not exclu-
sively [13]: among children younger than six months in
low- and middle-income countries, 63% are not exclu-
sively breastfed [14]. The length of postpartum amenor-
rhea depends on the breastfeeding practices. Women
often rely on these methods without knowing their limi-
tations. For women who are not breastfeeding, preg-
nancy can occur within 45 days postpartum even before
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the return of menses, and among women who are exclu-
sively or almost exclusively breastfeeding, around a quar-
ter (28%) are at risk of pregnancy before six months
postpartum [15, 16]. Third, women tend to adopt mod-
ern contraceptives only after the resumption of sexual
activity or menses [17]. These trends differ between
rural and urban areas, as suggested by qualitative re-
search in the urban setting of Ouagadougou, Burkina
Faso, where women interviewed did not consider amen-
orrhea as a protection against pregnancy and all had
adopted a contraceptive method or had the intention to
do so just before the resumption of sexual activity [18].
Fourth, opposition from partners or others, including for
religious reasons, can prevent women from practicing
contraception after birth. In West and Central Africa,
one in five women reported this barrier [9].
From the supply side: first, contraceptive services
may be limited to certain days of the week and only
offered once during the six-week postpartum period.
Second, service providers sometimes require amenor-
rheic postpartum women, who missed their 6-week
postpartum visit, to wait for the return of their men-
ses or take a pregnancy test before they can receive a
contraceptive method.
Several reviews of the literature and of PPFP interven-
tions in less developed countries were recently published
[19–22]. The World Health Organization (WHO) and
key partners published in 2013 programmatic strategies
for PPFP to support program managers in their efforts
to integrate PPFP into national and local health strat-
egies [23]. This document reviews the evidence accord-
ing to the RMNCH continuum as it offers convenient
entry points for PPFP interventions: antenatal care
(ANC), labor and delivery, postnatal care (PNC),
immunization, and child health. The following interven-
tions may have a positive effect on postpartum contra-
ceptive uptake: (1) counseling activities in ANC [24–28];
(2) provision of PPFP information, education, and coun-
seling materials before the woman is discharged home
from the health facility, including the provision of emer-
gency contraception backup for lactational amenorrhea
method (LAM) users [29–32]; (3) exclusive breastfeed-
ing promotion by community-based counsellors on ex-
clusive breastfeeding practices before five to six months
postpartum [33, 34]; (4) access to contraceptive methods
(including intrauterine devices (IUD)) immediately after
childbirth [35–37]; (5) provider competencies in quality
counseling and the provision of quality services with a
range of readily available products [38–40]; (6) longer
programs with several contact points between providers
and clients across the continuum of care versus short
ANC interventions [41–43]. While integration of PPFP
into immunization and child health services may yield
positive results, programmatic challenges (e.g., provider
competencies, time pressure, and competition with other
priority interventions) and policy barriers remain [44–48].
This said, the evidence is often weak or incomplete and
there are still knowledge gaps, particularly regarding stud-
ies that explore the desires, intentions, and priorities of
women or couples related to PPFP, which may differ
across settings, and that look at operationally-feasible
ways to integrate PPFP into existing ANC and PNC ser-
vices. Further, there is a limited number of methodologic-
ally rigorous trials that give a detailed description of tested
interventions and of how these were implemented.
Study overall objective and hypothesis
Against the above background and in light of the
socio-cultural and health service challenges related to
contraception in general and to PPFP in particular, we
plan a multipronged and multifaceted operational re-
search intervention: the YAM DAABO study (i.e., “your
choice” in Mooré, a national language in Burkina Faso).
The overall objective of this study is to determine the ef-
fectiveness of a context-sensitive PPFP intervention
package on the uptake of contraceptive methods during
the first year postpartum compared with the general
standard of care. We assume that a package containing
different components is more effective than a single inter-
vention to increase contraceptive uptake. The other work-
ing hypotheses for the package interventions to be
effective and sustainable are as follows: they should (1)
strengthen existing ANC and PNC services in primary
health care centers; (2) account for the views and prefer-
ences of key actors, including those of clients; (3) be in
line with national health policies; and (4) take into consid-
eration the scarcity of public resources. Under Methods,
we outline preliminary contents of the package.
Study countries
The study will be implemented in two countries: Burkina
Faso (by the Health Sciences Research Institute / Institut
de Recherche en Sciences de la Santé (IRSS) in
Ouagadougou) and the Democratic Republic of Congo
(DRC) (by the School of Public Health / Ecole de Santé
Publique (ESP) of Kinshasa University). Table 1 presents
relevant reproductive health and health service
utilization indicators based on DHS data from Burkina
Faso (2010) and the DRC (2013–2014) [49, 50].
Methods
Conceptual framework
To ensure that the PPFP intervention package that will
emerge from this trial strengthens the existing ANC and
PNC services in primary health care settings, and is effect-
ive, safe, sustainable, scalable, and culturally-appropriate,
this health services research is grounded by two con-
ceptual frameworks. First, the WHO Health Systems
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Framework with its six system building blocks (leader-
ship/governance, health care financing, health workforce,
medical products and technologies, information and re-
search, and service delivery) [51]. Second, the WHO
framework for ensuring human rights in the provision of
contraceptive information and services [52] to foster an
approach towards optimizing contraceptive choices within
the context of repeated visits during routine ANC, post-
partum care, and PNC, as recommended by the WHO
[53]. This framework comprises the following elements:
non-discrimination, availability, accessibility, acceptability,
quality, informed-decision making, protection of privacy
and confidentiality, participation, and accountability. Both
frameworks are interrelated and will inform the design of
the PPFP intervention package and the research instru-
ments. For the qualitative and quantitative research
phases, the research team will pay attention that no
women or adolescent girls will be discriminated
against (such as for study participation or in the
provision of PPFP information and services), based on
their age, marital status, HIV status, membership of a
minority, or other medical or social criteria. While
ensuring that human rights are upheld in the design
and implementation of the study is critical and ap-
pears feasible, the researchers are aware that address-
ing the barriers and catalysts related to the six health
system building blocks through the perspective of
PPFP is vast and extends well beyond the available
study timeframe and resources. For example, the re-
search does not have the objective nor the means to
test interventions aimed at reducing health service
costs or improving the health information system re-
lated to PPFP.
Phases of the study
The research entails a complex intervention design with
three interacting study phases: a pre-formative phase, a
formative phase, and an intervention phase. Figure 1
summarizes the overall study design. These phases are
Table 1 Selected indicators on reproductive health and utilization of maternal and child health services in Burkina Faso (2010) and
the Democratic Republic of Congo (DRC) (2013–2014)
Burkina Faso DRC
Contraceptive unmet need among postpartum women
Right after childbirth (%) 89 66
After six months of amenorrhea (%) 50 48
At the end of amenorrhea (%) 24 28
Median duration of breastfeeding (months) 24 22
Exclusive breastfeeding (months) 0.6 2
Median duration of postpartum abstinence (months) 8 8
Median duration of amenorrhea (months) 12 13
Median duration of birth intervals (months) 36 31
Proportion of children born less than 24 months after their previous siblings (%) 13 27
Proportion of women attending antenatal care (%) 95 88
Proportion of deliveries in a health facility (%) 66 80
Proportion on postpartum women receiving prenatal care within 48 h of childbirth (%) 72 44
Proportion of children 12–23 months having received all recommended vaccines (%) 81 41
Sources: [49, 50]
Fig. 1 Overall study design
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interconnected and have specific objectives, methodolo-
gies, and results. Although the proposed methods in
each phase are not complex per se, the overall interven-
tion design is complex as it contains “several interacting
components”, deals with a “number and difficulty of be-
haviors required by those delivering or receiving the
intervention”, and engages a “number of groups or
organizational levels targeted by the intervention”,
among others [54]. The design follows the recommenda-
tions from the Medical Research Council (2008/2010) to
develop a complex intervention, determine its feasibility,
implement, and evaluate [54].
The specific objective of the pre-formative phase is to
establish a sampling frame of potential study sites by
mapping primary health centers according to
pre-established criteria. Health centers are eligible if (1)
they offer the continuum of ANC, delivery, and PNC;
(2) they provide a selection of at least three modern
contraceptive methods, including a barrier method such
as condom, a short-term method such as pills, a
long-term method such as intra-uterine device and re-
ferrals for permanent methods to clients; (3) there were
no stock-outs of contraceptives during the preceding six
months; (4) they have on average at least thirty deliveries
per month; (5) they are situated within four hours drive
from the research center; and (6) they are willing to par-
ticipate. Based on this sampling frame, in each country,
three health centers will be chosen conveniently for the
formative phase while eight others will be allocated ran-
domly to the experimental and control groups of the
intervention phase.
The specific objective of the formative phase is to
identify through participatory action research a context--
specific package of PPFP interventions to be imple-
mented during the intervention phase. Initially, with a
view to informing the design of the PPFP intervention
package, we will seek the participation of a variety of
stakeholders to identify barriers and catalysts related to
PPFP uptake. Based on field observations from our re-
search teams, service providers did not integrate system-
atically PPFP into ANC, delivery care or PNC, and there
were no dedicated PPFP job aids or counseling tools, al-
though PPFP information and services should be part of
the maternal health continuum of care according to na-
tional recommendations. To address these knowledge
gaps in our study countries (and in other Sub-Saharan
countries in general) and to answer providers’ request
for a counseling tool to help them better and more sys-
tematically support women, we identified the following
potential components that would ensure that PPFP is
delivered as part of the intervention package: (i) a coun-
seling tool for clients and providers that is specific to
PPFP and for use during ANC and PNC services, and
(ii) refresher trainings to enhance service providers’
PPFP knowledge and skills. This preliminary set of inter-
ventions will be enriched and undergo changes as results
of the participatory action research engaging stake-
holders are made available. To be integrated into the
final package, interventions will need to take into ac-
count existing human resources and clinical capacity at
the primary health care level, as wells as costs, accept-
ability, feasibility, and other field considerations.
The specific objective of the intervention phase is to
determine, through a cluster randomized controlled
(RCT) trial design, the effect of the PPFP intervention
package on the uptake of contraceptive methods during
the extended postpartum period, in comparison with the
standard of care. The intervention phase also integrates
qualitative research that is aimed at identifying oper-
ational reasons for success or failure in the implementa-
tion of PPFP services.
The phased approach adopted in this study, with the
different specific objectives, levels of activities, and inter-
mediate and final results, is underpinned by the theory
of change [55]. This theory is helpful in the design of
complex interventions such as the one proposed in this
trial: it takes as a starting point the ultimate objective of
meeting the contraceptive needs of women during the
extended postpartum period; it then engages various
stakeholders in identifying the desired intermediate re-
sults that aim to strengthen ANC and PNC services, be-
fore formulating the interventions that are needed to
achieve these results. This backward planning allows
from the outset a dynamic and participatory approach
through which the final PPFP intervention package will
be designed. The theory of change will be applied to
design quantitative process indicators and qualitative
tools aimed at assessing the level of implementation of
the intervention package and how each intervention will
be implemented. These process indicators and informa-
tion will be key to help explain why the package is ef-
fective or not and highlight operational barriers and
enablers useful for future scale-up and implementation
research.
We will present the details of the qualitative research
and the cluster RCT in the following sections.
Qualitative research
General design
For the qualitative components of the study (in the for-
mative phase and embedded in the intervention phase),
we adopt a participatory approach using focus group dis-
cussions (FGD) and in-depth interviews (IDI) with mem-
bers of the community (women, adolescent girls,
partners, people with influence), health staff (service
providers, managers), and national policymakers.
The formative phase will take place in each country
in three conveniently sampled health centers and their
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respective coverage areas. These sites are drawn from
the sampling frame established in the pre-formative
phase.
For the identification of PPFP barriers and catalysts,
we plan separate FGDs of six to ten participants for the
following categories of individuals: (a) women who are
currently pregnant or who delivered at the health center
during the previous 12 months – the age will determine
their allocation to subgroups: adolescent girls (≤
19 years), women 20–39 years, women ≥40 years; (b)
men (25–40 years) who are partners or husbands of
women who are pregnant or who delivered at the health
center during the previous 12 months; and (c) service
providers. We will conduct IDIs with clinic managers,
policymakers, and individuals whom local informants
will identify in each recruitment zone as influential, such
as religious leaders, village chiefs, community personal-
ities, or others. Adult participants will give their in-
formed consent. Non-adult participants will give their
informed assent and their respective parents or guard-
ians their informed consent. The interview guides will
cover the following themes related to PPFP: knowledge,
attitudes and practices; socio-cultural and health systems
barriers and catalysts; and quality of care, including hu-
man rights considerations.
We will pilot a draft of the PPFP counseling tool and
finalize it during the formative phase using participatory
action research principles. We will engage service pro-
viders and clients to design and implement the tool and
participate in research to assess its ease of understand-
ing, relevance, contents related to human rights princi-
ples, and potential impact. Service providers will be
trained on the use of the counseling tool through theor-
etical sessions and role plays, before implementing it
with clients in health centers. These clients will be preg-
nant women attending ANC services or women who de-
livered in the previous 12 months. We plan separate
FGDs with service providers who offered the counseling
tool and with women who received counseling with the
tool. If partners attended a counseling session with the
tool, they will be invited to a separate FGD to provide
feedback.
Qualitative research embedded in the intervention
phase will take place at the eight health centers random-
ized to the experimental or control groups. In line with
the theory of change approach, it will consist of an im-
plementation evaluation to analyze barriers and catalysts
related to the delivery of PPFP services, assess interven-
tion fidelity (in the experimental group), and explore ap-
proaches for scaling up. Separate FGDs are planned for
service providers, participants (≤ 19 years, 20–39 years,
≥ 40 years), and their partners. IDIs are planned for
clinic managers. The interview guides will cover the fol-
lowing themes related to PPFP service provision:
operational barriers and catalysts; quality of care; human
rights; and scaling-up considerations.
Qualitative data management and analysis
The semi-structured interview guides are in French. In
each country, we will recruit a team of social scientists
with relevant experience in qualitative methods and in
working in the respective local languages (Mooré in Bur-
kina Faso and Lingala in the DRC). We will train them
on how to conduct the interviews, paying attention to
finding the most appropriate and clear language to ex-
press technical terms in the local languages.
The interviews will take place in a location guarantee-
ing privacy (for example, an empty room in the health
facility). The interviews will be audiotaped after obtain-
ing the agreement from participants. Research assistants
will transcribe and translate the audio records into
French using Microsoft Word. Accuracy checks will be
done by comparing transcripts with audio files.
We will perform a thematic analysis using QSR NVivo
11 software, a qualitative research management tool. We
will establish a basic codebook, which describes all the
nodes, and use it to code data. We will enrich the code-
book with new emerging nodes during the coding
process. Data will be coded by research assistants. To
ensure quality of data coding, we will first ask research
assistants to code a common transcription sample be-
fore performing inter-rater reliability testing by comput-
ing the Cohen’s Kappa coefficient. We will consider a
Kappa coefficient of 0.8 and above to be an acceptable
concordance threshold.
Results from the formative phase will be presented
and discussed during a research workshop with the key
members of each country research team, including se-
lected service providers from the formative sites as well
as the WHO coordinating team. Country participants
will be iteratively invited to express their views on pos-
sible interventions when examining the potential effect-
iveness of possible interventions, as well as acceptability
to women and providers, feasibility, “integrability” into
the RMNCH continuum, sustainability, and scalability.
Through iterative individual voting and discussion pro-
cesses, we aim to reach a consensus on the final PPFP
intervention package.
Cluster randomized-controlled trial
This is a two-group, non-blinded cluster RCT conducted
in the primary health centers in Burkina Faso and the
DRC (see Fig. 2 for the cluster RCT flow diagram, and
Fig. 3 for the schedule of enrolment, interventions, and
assessments (SPIRIT template)). Randomization to con-
trol and intervention arms is at the level of the health
center. Participants allocated to the experimental group
will receive the PPFP intervention package and those
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allocated to the control group will receive usual care.
Service providers who have midwifery and contraceptive
skills and who offer ANC, delivery, and PNC services
will implement the clinical components of the PPFP
package. The cluster RCT design is justified by the fact
that the different components of the PPFP intervention
package, which will eventually be identified, may not be
delivered directly to individual participants but only ap-
plied at the level of the health center (e.g. refresher
training for service providers, optimization of health ser-
vice organization).
Outcome measures
Case-report forms (CRFs) will be developed for quan-
titative indicators. The primary outcome is the uptake
of modern contraceptive methods at twelve months
postpartum (proportion of women using modern con-
traceptives at twelve months in the experimental vs.
control group).
Secondary outcomes include: use of a modern contra-
ceptive method upon clinic discharge (24–48 h), at six
days, six weeks, six months, and nine months postpar-
tum. Intermediate outcomes include the decision taken
at different follow-up points to use a contraceptive
method. The proposed postpartum follow-up schedule is
in line with current national practices in both study
countries, although it is slightly different from those rec-
ommended by WHO [53]. In 2013, WHO issued the fol-
lowing recommendations for the timing of postnatal
visits: on day 1 (24 h), on day 3 (48–72 h), between days
7 and 14, and at week 6.
Fig. 2 Flow diagram of the cluster randomized control trial in each study country
Fig. 3 Schedule of enrolment, interventions, and assessments for the cluster randomized controlled trial phase in each study country
(SPIRIT template)
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Process measures
It is important to note that the cluster RCT is designed to
evaluate the effectiveness of a package of PPFP interven-
tions and cannot indicate which specific intervention in
the package will have the most impact on postpartum
contraceptive uptake. Therefore, we plan a process evalu-
ation with the objectives to: (1) detect implementation is-
sues that could be explanatory in case the intervention is
not effective; and (2) facilitate the replication and scale-up
of the intervention if it is proven effective. We have there-
fore developed process indicators in the CRFs to help as-
sess the level of implementation of selected interventions
of the package. Event logs and monitoring visit checklists
implemented at health centers will offer other sources of
process-oriented information. The qualitative research
embedded in the intervention phase will further contrib-
ute to understanding the barriers and enablers related to
the delivery of PPFP and to the implementation of the
trial. The process indicators and the embedded qualitative
research will give clues as to the components of the pack-
age that participants and providers will perceive as having
a greater impact.
Sample size calculation
The sample size is estimated based on the following as-
sumptions: among women at six months postpartum, DHS
data report 7.2% of use of any method (modern or trad-
itional) in Burkina Faso [56] and 5.1% of use of modern
methods in the DRC [10]. These figures allow us to assume
that around 5.0% of participants in the control group in
both countries will adopt a modern contraceptive at six
months postpartum. In Burkina Faso and the DRC, women
in the general population have a similar contraceptive
prevalence rate for modern methods of 15.0%, which allows
us to assume that around 15.0% of participants in the ex-
perimental group will use a modern method at six months
postpartum. Given the high unmet need for PPFP, we as-
sume that an increased proportion of at least 20.0% of par-
ticipants in the experimental group will adopt a modern
method at twelve months postpartum. This corresponds to
a difference of 15.0% between the experimental group
(20.0%) and the control group (5.0%). Therefore, assuming
an intra-cluster (health center) correlation coefficient of
0.02, we used PASS 11 Software (Power Analysis and Sam-
ple Size) for sample size calculation: the experimental group
and the control group will each have four study sites with
at least 60 participants per site in each study country [57].
This allows for a statistical power of 93% to detect a differ-
ence of 15% to a level of significance of 5% at the individual
level (and not at the facility level). Assuming a 10% partici-
pant loss to follow up, each site will recruit at least 70 preg-
nant women. This equates to a cohort of 280 pregnant
women in each group (4 sites × 70 participants), and in
total 560 participants per country (280 participants × 2
study groups). Therefore, across both countries, the study
will have a total sample size of 1120 participants (560 in the
experimental and 560 in the control group).
Eligibility criteria for clusters (health centers) and
participants (women)
The study will be conducted in eight primary health cen-
ters in each country. The eligibility criteria of health
centers were described above under the objective of the
pre-formative phase. All pregnant women will be eligible
to participate in the study if (1) they are in their third
pregnancy trimester; (2) the status of the pregnancy and
of the woman allows for a birth at the health center; (3)
the woman has the intention to attend ANC, delivery,
and PNC at the health center; (4) the woman does not
participate in another study; and (5) an informed con-
sent is obtained.
Interventions
The health centers of the experimental group will imple-
ment the PPFP intervention package. The control group
will implement usual care. Depending on the nature of
the final package, some interventions may be imple-
mented before participant recruitment (such as PPFP re-
fresher training for service providers), while others will
be implemented afterwards (such as using the PPFP
counseling tool with participants).
Randomization
In each country, the eight sites are matched by pairs ac-
cording to (1) the average number of deliveries per
month; (2) the ratio of health workers per population;
and (3) the settings (rural, urban). Within each of the
four pairs, we will randomly select the site assigned to
the experimental intervention. This randomization is
performed four times (once for each pair) in each study
country. No restriction in the randomization process is
required and masking cannot be done. All consecutive
and eligible participants will be included in the clusters.
Data source and collection
Data on key outcome measures as well as quantitative
process indicators will be collected on paper-based
CRFs. The WHO team in Geneva will develop the CRFs
with inputs from the country research teams. We will
test advanced drafts with an appropriate sample of ser-
vice providers and mock clients from the formative
phase sites before finalizing the forms. Each health
center of the cluster RCT will have a research assist-
ant who will be trained to adhere to the study man-
ual and standard operating procedures for data
management which are common to both study coun-
tries and have been developed by WHO. The infor-
mation reported on the CRFs will be checked for
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accuracy and completeness several times at different
levels by field coordinators and data managers.
Data management
As for other multicenter trials conducted and sponsored
by the UNDP/UNFPA/UNICEF/WHO/World Bank Spe-
cial Programme of Research, Development and Research
Training in Human Reproduction (HRP) at WHO in
Geneva, we will perform data entry and data quality
monitoring using a web-based data management system.
The Biostatistics and Data Management team at HRP
will develop it through OpenClinica (version 3.11), an
electronic data capture software for clinical research,
which includes programmed edit checks for data accur-
acy, completeness, and consistency, reduces delays in
data queries and problem resolution, and allows the
dataset to be quickly available. The OpenClinica system
is a highly secure, open-source, and reliable web-based
software solution, which is fully compliant with Good
Clinical Practice (GCP) and regulatory guidelines and
HRP/WHO Standard Operating Procedures for clinical
trial managements.
Data entry will be performed locally in Ouagadougou
and Kinshasa by the collaborating research centers and
checked by the WHO team in Geneva. We will train the
country teams in data entry and data management using
the OpenClinica system. Country research teams will be
responsible for verifying the data, uploading them onto
shared files and entering the data into the OpenClinica
system. To reduce errors, double data entry will be per-
formed. The system will automatically generate queries on
data (missing values, outliers, inconsistencies, and other
errors). The WHO team will monitor data quality. Ques-
tions about data inconsistencies or missing values will be
sent to sites using standardized forms and will be resolved
on an ongoing basis. Data transmission will be encrypted
to ensure data integrity and confidentiality of participants.
Access to the data will be password protected: only autho-
rized users will be allowed access to the data.
Statistical analysis
We will prepare a comprehensive statistical analysis plan
before finishing recruitment for the study. The participant
will form the unit of analysis and intra-cluster correlation
coefficient will be accounted for. All analysis will be by
intention to treat. We will perform descriptive statistics by
computing means, standard deviations, and minimum and
maximum values for continuous variables, and frequen-
cies and percentages for categorical variables. As part of
quality control and descriptive analysis of the data, we will
examine the distribution of variables to detect outliers.
Descriptive statistics will be tabulated for individual clus-
ters and aggregated across clusters. We will use IBM SPSS
Statistics 21, R, STATA 13, or SAS statistical packages for
the analysis. We will present the results according to the
2010 CONSORT Statement checklist and its extension for
cluster studies [58].
Intervention fidelity
Threats to the PPFP intervention package fidelity will be
minimized by providing an initial training to service pro-
viders of the experimental sites and ongoing monitoring
and supportive supervision visits to assess adherence to
the intervention package. The WHO coordination team
will hold weekly teleconferences with each country team
and conduct periodic site visits to assess implementation
progress. An action plan will be implemented if there
are any concerns regarding adherence to the interven-
tion package.
Ethics
In the design of this trial we have taken into account the
recommendations provided by The Ottawa Statement
on the Ethical Design and Conduct of Cluster Random-
ized Trials [59]. This protocol was peer-reviewed by the
Research Project Review Panel (RP2) of the HRP. RP2
and the WHO Research Ethics Review Committee, Gen-
eva, Switzerland, approved the study protocol as well as
the respective ethical committees in Burkina Faso (see
Declarations for details). Upon completion of the forma-
tive phase, we will submit to the same global and local
ethical committees the amendments to the protocols,
which will include the finalized PPFP intervention pack-
age and the related research instruments for the experi-
mental phase.
Discussion
Despite the proven benefits of modern contraceptive
use, the unmet need for postpartum family planning re-
mains unacceptably high. This is puzzling as survey find-
ings continue reporting that most couples wish to space
their children by at least two years [60], and women ac-
cess health services more often during pregnancy, deliv-
ery, and the first year of their child’s life than other
periods. During the multiple opportunities given by this
heightened contact with health services, we would ex-
pect an increase in demand for and supply of contracep-
tive information and services.
Given the known reliance on amenorrhea from breast-
feeding and abstinence for protection from pregnancy
for up to a year postpartum, is it then worth investing
energy and resources into PPFP programming during
the first year postpartum? Despite these practices, DHS
data show that the unmet need for PPFP in Burkina Faso
and the DRC, as well as in Sub-Saharan Africa in gen-
eral, remains critically high and it is important to ex-
plore the optimal programmatic approaches to address
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and resolve it. To this end, different strategies have been
explored:
First, there has been a renewed interest on highly ef-
fective long-acting and reversible methods, such as im-
mediate postpartum IUD. These programs have shown
promising results, although they require major undertak-
ing in terms of logistics, competency training of health
staff, and demand creation [37]. Burkina Faso and the
DRC have recently given commitments to piloting such
programs.
Second, targeted investment to promote LAM for up
to six months and switching to another method appears
justified from the RMNCH perspective. Tabulations of
DHS data on exclusive breastfeeding from Burkina Faso
and the DRC are not encouraging and reflect the situ-
ation in other low-income countries [61]. The median
duration of exclusive breastfeeding changed minimally
in Burkina Faso between 1993 and 2010 (0.4 and
0.6 month respectively), and in the DRC between 2007
and 2013–14 (1.4 and 2.2 months respectively). This
may be due to widespread early supplementation prac-
tices that are entrenched by traditions and hard to influ-
ence. The median duration of amenorrhea is twelve
months in both countries and suggests that breastfeed-
ing, although not exclusive, must be frequent enough to
induce an amenorrheic state. Therefore, having health
staff promoting LAM at length may not be an efficient
use of limited resources.
Third, with a median duration of postpartum abstin-
ence close to eight months in both study countries, it
appears that the immediate postpartum or the six-week
postpartum visit dedicated to contraceptive services may
not respond to women’s demand. Instead of the targeted
“high-dose, low-frequency” strategies that promote a
method over another and restrict services to a narrow
window period, a “low-dose, high frequency” approach
during the end of pregnancy and the first year postpar-
tum to deliver contraceptive information and services
may be a more appropriate pathway to respond to the
wishes and situations of each postpartum woman and
couple: giving information to women and couples, in-
cluding on benefits and limitations of PPFP and of avail-
able contraceptive methods, and letting them choose.
The latter choice-based strategy underpins our health
service trial, which also stands out for other reasons.
First, given the growing availability of ANC, delivery,
and PNC services in primary health centers in
low-resource countries, we believe that there is an ur-
gent need to design, test, and scale up effective, afford-
able, and sustainable PPFP interventions that are not
only respectful of the intentions, decisions, and situa-
tions of clients but that can also reinforce the existing
RMNCH continuum of care. This will allow to minimize
missed health services opportunities to address the
contraceptive needs of postpartum women and couples.
Second, due to the complex social, cultural and religious
challenges and opportunities surrounding contraceptive
use, our research assumes that this can only be accom-
plished by following participatory action research princi-
ples. Engaged stakeholders include adolescents, women,
men, key community members, health staff,
policy-makers, and researchers, whose views and inputs
will contribute to shaping the PPFP intervention
package.
Several changes may happen as a consequence of the
study. At the individual level, knowledge, attitudes, and
behaviors of women and couples toward PPFP will likely
be influenced by a set of inexpensive interventions. At
the health service delivery level, implementation of
the intervention phase will probably require a shift in
behavior and accountability of service providers with
regard to the systematic integration of PPFP into
their clinical practice, and optimization of health ser-
vice organization to ensure a reliable availability of
competent staff and contraceptive methods and sup-
plies when they are needed.
Limitations
Foreseen limitations and challenges regarding this com-
plex intervention include coordination difficulties with
and between study countries and study sites, political
and policy changes, possible time struggle in delivering
the intervention and respecting its fidelity, and main-
taining the trial timelines. The cluster RCT is not de-
signed to determine which components of the
intervention package will have an effect, or not, on
contraceptive uptake. To this effect, we have embedded
qualitative research and process-oriented indicators in
the quantitative research. Although effective in exploring
sensitive issues, such as sexuality and contraception, par-
ticipatory approaches in qualitative research face limita-
tions, including selection bias (e.g., convenience
sampling of informants) and response bias (e.g. social
desirability, recall bias) – the latter can also affect quan-
titative measures. To mitigate qualitative research weak-
nesses, we will sample a sufficient number of
participants of different categories to ensure that infor-
mation saturation can be reached. Findings will also be
validated iteratively, including in research workshops
that will gather key stakeholders. The overall strengths
of the proposed design outweigh its limitations and ex-
perienced researchers are joining efforts to form the
study team at country and global levels.
Scaling up
Feasibility and scalability in other low-resource settings
are among the criteria that will guide the selection of
the final package of interventions. This will ensure that
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the package in its entirety is widely applicable to and
easily scalable in other similar settings. Transparency
about the tested interventions and rigorous qualitative
and quantitative metrics are paramount in this trial. The
results of this trial will be applicable directly to other
resource-constrained primary health care settings in
Sub-Saharan Africa where RMNCH services are offered.
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